Document is current
Any future updates will be listed below
-
Authors
Pallett, Laura J. https://orcid.org/0000-0002-4161-9462
Swadling, Leo https://orcid.org/0000-0002-0537-6715
Diniz, Mariana
Maini, Alexander A.
Schwabenland, Marius https://orcid.org/0000-0003-2205-5427
Gasull, Adrià Dalmau https://orcid.org/0000-0002-8410-8048
Davies, Jessica
Kucykowicz, Stephanie https://orcid.org/0000-0002-8849-218X
Skelton, Jessica K.
Thomas, Niclas
Schmidt, Nathalie M. https://orcid.org/0000-0002-9841-8418
Amin, Oliver E.
Gill, Upkar S.
Stegmann, Kerstin A.
Burton, Alice R.
Stephenson, Emily
Reynolds, Gary
Whelan, Matt https://orcid.org/0000-0003-0441-3358
Sanchez, Jenifer
de Maeyer, Roel https://orcid.org/0000-0003-4041-0867
Thakker, Clare
Suveizdyte, Kornelija
Uddin, Imran https://orcid.org/0000-0003-0736-3149
Ortega-Prieto, Ana M. https://orcid.org/0000-0002-9023-0103
Grant, Charlotte
Froghi, Farid
Fusai, Giuseppe
Lens, Sabela
Pérez-del-Pulgar, Sofia https://orcid.org/0000-0002-9890-300X
Al-Akkad, Walid
Mazza, Giuseppe
Noursadeghi, Mahdad https://orcid.org/0000-0002-4774-0853
Akbar, Arne https://orcid.org/0000-0002-3763-9380
Kennedy, Patrick T. F.
Davidson, Brian R.
Prinz, Marco https://orcid.org/0000-0002-0349-1955
Chain, Benjamin M. https://orcid.org/0000-0002-7417-3970
Haniffa, Muzlifah https://orcid.org/0000-0002-3927-2084
Gilroy, Derek W. https://orcid.org/0000-0003-3476-0844
Dorner, Marcus https://orcid.org/0000-0003-0321-4226
Bengsch, Bertram https://orcid.org/0000-0003-2552-740X
Schurich, Anna https://orcid.org/0000-0002-2525-3114
Maini, Mala K. https://orcid.org/0000-0001-6384-1462
- License Information
-
More Information
Article History
Received: 31 October 2018
Accepted: 12 December 2022
First Online: 25 January 2023
Competing interests
: M.K.M. and L.J.P. have received project funding from Gilead for research unrelated to this manuscript. M.K.M. has sat on advisory boards/provided consultancy for Gilead, Roche, GSK and VirBiosciences. L.J.P. has sat on advisory boards/provided consultancy for Gilead and SQZ Biotech. M.K.M. and L.J.P. have a patent application P116607GB filed through UCL-Business on the use of CD14<sup>+</sup>CD8<sup>+</sup> T cells.
